Prevalence and Correlates of Depressive Symptoms Among People Living with HIV Attending Tertiary Care Hospitals in Oman

Overview

Journal Pan Afr Med J

Date 2020 Nov 27

PMID 33244353

Citations 3

Authors

Abdullah Al Madhani

Lara Al Harthi

Abdullah Balkhair

Moon Fai Chan

Badar Sr Albusaidi

Nasser Al Sibani

Samir Al-Adawi

Affiliations

Soon will be listed here.

Abstract

Introduction: depressive symptoms have been widely reported among people living with HIV (PLHIV) around the world. The extent of this on PLHIV in the Arabian Peninsula is unclear. This study aims to examine the prevalence of depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9) in adult Omani patients with HIV attending a tertiary care hospital. It also aims to investigate the relationship between clinical and socio-demographic variables and depressive symptoms.

Methods: LHIV, age >18 (n=101), participated in the study who were followed up at a teaching hospital in Muscat, Oman. Participants were identified by a convenient and consecutive sampling of eligible patients who came for consultation on the days that the investigator conducted recruitment. The presence of depressive symptoms was quantified by the Patient Healthcare Questionnaire-9 (PHQ-9). Various socio-demographic backgrounds and risk factors will be also sought as well as activities of daily living (ADL). Chi-square test, Fisher´s exact test, t-test and logistic regression were used to explore which variables were associated with patients having depressive symptoms.

Results: the prevalence rate of depressive symptoms in this cohort was 41.6%. Depression among PLHIV was found to be significantly associated with age (p <0.001), HIV disease duration (p <0.001), total dependency for ADL (p <0.001) and comorbid hypertension (p <0.001).

Conclusion: depressive symptoms are common in Omani patients living with HIV. HIV care providers are urged to be vigilant to recognize depressive symptoms in these mood-vulnerable populations and to call for a multidisciplinary team with mental health professionals, for the prevention and treatment of depressive symptoms among PLHIV in Oman.

Citing Articles

Quality of Life of People Living with HIV on Antiretroviral Therapy: A Cross-Sectional Study in Monastir, Tunisia.

Berrezouga L, Kooli I, Marrakchi W, Harzallah G, Chakroun M HIV AIDS (Auckl). 2023; 15:671-682.

PMID: 38028190 PMC: 10644839. DOI: 10.2147/HIV.S430376.

Prevalence and related factors of depressive symptoms among HIV/AIDS in Ningbo, China: A cross-sectional study.

Chen S, Hong H, Xu G Front Psychiatry. 2022; 13:1004318.

PMID: 36299546 PMC: 9592111. DOI: 10.3389/fpsyt.2022.1004318.

Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV.

Hoare J, Sevenoaks T, Mtukushe B, Williams T, Heany S, Phillips N Curr HIV/AIDS Rep. 2021; 18(6):569-580.

PMID: 34792706 PMC: 8600343. DOI: 10.1007/s11904-021-00583-w.

References

Gebrezgiabher B, Abraha T, Hailu E, Siyum H, Mebrahtu G, Gidey B . Depression among Adult HIV/AIDS Patients Attending ART Clinics at Aksum Town, Aksum, Ethiopia: A Cross-Sectional Study. Depress Res Treat. 2019; 2019:3250431. PMC: 6378035. DOI: 10.1155/2019/3250431. View

Kong D, Solomon P, Dong X . Depressive Symptoms and Onset of Functional Disability Over 2 Years: A Prospective Cohort Study. J Am Geriatr Soc. 2019; 67(S3):S538-S544. PMC: 9942515. DOI: 10.1111/jgs.15801. View

Balkhair A, Al-Muharrmi Z, Ganguly S, Al-Jabri A . Spectrum of AIDS Defining Opportunistic Infections in a Series of 77 Hospitalised HIV-infected Omani Patients. Sultan Qaboos Univ Med J. 2013; 12(4):442-8. PMC: 3523993. DOI: 10.12816/0003169. View

Seaberg E, Munoz A, Lu M, Detels R, Margolick J, Riddler S . Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005; 19(9):953-60. DOI: 10.1097/01.aids.0000171410.76607.f8. View

Phillips A, Stover J, Cambiano V, Nakagawa F, Jordan M, Pillay D . Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa. J Infect Dis. 2017; 215(9):1362-1365. PMC: 5451603. DOI: 10.1093/infdis/jix089. View

Dal-Bo M, Manoel A, Filho A, Silva B, Cardoso Y, Cortez J . Depressive Symptoms and Associated Factors among People Living with HIV/AIDS. J Int Assoc Provid AIDS Care. 2013; 14(2):136-40. DOI: 10.1177/2325957413494829. View

Millar B, Starks T, Gurung S, Parsons J . The Impact of Comorbidities, Depression, and Substance Use Problems on Quality of Life Among Older Adults Living With HIV. AIDS Behav. 2016; 21(6):1684-1690. PMC: 5423848. DOI: 10.1007/s10461-016-1613-5. View

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

OCleirigh C, Newcomb M, Mayer K, Skeer M, Traeger L, Safren S . Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a "prevention for positives" study. AIDS Behav. 2013; 17(5):1764-9. PMC: 3752694. DOI: 10.1007/s10461-013-0462-8. View

10.

Brawner B, Jemmott L, Wingood G, Reason J, Daly B, Brooks K . Feelings Matter: Depression Severity and Emotion Regulation in HIV/STI Risk-Related Sexual Behaviors. J Child Fam Stud. 2022; 26(6):1635-1645. PMC: 9380447. DOI: 10.1007/s10826-017-0674-z. View

11.

Al-Jabri A, Al-Abri J . Knowledge and attitudes of undergraduate medical and non-medical students in Sultan Qaboos University toward acquired immune deficiency syndrome. Saudi Med J. 2003; 24(3):273-7. View

12.

Sternhell P, Corr M . Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Aust N Z J Psychiatry. 2002; 36(4):528-33. DOI: 10.1046/j.1440-1614.2002.00999.x. View

13.

Al-Ghafri G, Al-Sinawi H, Al-Muniri A, Dorvlo A, Al-Farsi Y, Armstrong K . Prevalence of depressive symptoms as elicited by Patient Health Questionnaire (PHQ-9) among medical trainees in Oman. Asian J Psychiatr. 2014; 8:59-62. DOI: 10.1016/j.ajp.2013.10.014. View

14.

Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain M, Komba P . The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. J Int Assoc Provid AIDS Care. 2013; 13(4):346-52. DOI: 10.1177/2325957413503368. View

15.

Campos L, Crosland Guimaraes M, Remien R . Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav. 2008; 14(2):289-99. PMC: 2859347. DOI: 10.1007/s10461-008-9435-8. View

16.

Ngum P, Fon P, Ngu R, Verla V, Luma H . Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study. Neurol Ther. 2017; 6(1):103-114. PMC: 5447558. DOI: 10.1007/s40120-017-0065-9. View

17.

Sambamoorthi U, Walkup J, Olfson M, Crystal S . Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. J Gen Intern Med. 2000; 15(5):311-20. PMC: 1495453. DOI: 10.1046/j.1525-1497.2000.06219.x. View

18.

Khamis F, Al Noamani J, Al Naamani H, Al-Zakwani I . Epidemiological and Clinical Characteristics of HIV Infected Patients at a Tertiary Care Hospital in Oman. Oman Med J. 2018; 33(4):291-298. PMC: 6047180. DOI: 10.5001/omj.2018.55. View

19.

Sweileh W . Global research output on HIV/AIDS-related medication adherence from 1980 to 2017. BMC Health Serv Res. 2018; 18(1):765. PMC: 6180611. DOI: 10.1186/s12913-018-3568-x. View

20.

Katz S . Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983; 31(12):721-7. DOI: 10.1111/j.1532-5415.1983.tb03391.x. View